← Open Payments lookup

KENNETH TACKETT: Open Payments

NPI 1063099554 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,292 in 109 payments from 16 companies in 2025. Trend: 2023 $455 · 2024 $1,686 · 2025 $2,292

Food & beverage: $2,292
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$444
Otsuka America Pharmaceutical, Inc.14$259
Takeda Pharmaceuticals U.S.A., Inc.11$237
ABBVIE INC.11$235
Teva Pharmaceuticals USA, Inc.12$202
Alkermes, Inc.6$140
Vanda Pharmaceuticals Inc.7$133
Neurocrine BioSciences, Inc.6$113
Lundbeck LLC5$104
E.R. Squibb & Sons, L.L.C.4$88

Products named: CAPLYTA, REXULTI, TRINTELLIX, VRAYLAR, ARISTADA, FANAPT, INGREZZA, UZEDY.

Industry payments across TX — which companies pay providers there.